ATE272643T1 - Verfahren zur herstellung eines reinen, pharmacopoiealgrad amorphes form von cefuroxim axetil - Google Patents
Verfahren zur herstellung eines reinen, pharmacopoiealgrad amorphes form von cefuroxim axetilInfo
- Publication number
- ATE272643T1 ATE272643T1 AT01931992T AT01931992T ATE272643T1 AT E272643 T1 ATE272643 T1 AT E272643T1 AT 01931992 T AT01931992 T AT 01931992T AT 01931992 T AT01931992 T AT 01931992T AT E272643 T1 ATE272643 T1 AT E272643T1
- Authority
- AT
- Austria
- Prior art keywords
- amorphous form
- pure
- pharmacopoieal
- producing
- cefuroxime axetil
- Prior art date
Links
- KEJCWVGMRLCZQQ-YJBYXUATSA-N Cefuroxime axetil Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(=O)OC(C)OC(C)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 KEJCWVGMRLCZQQ-YJBYXUATSA-N 0.000 title abstract 5
- 238000004519 manufacturing process Methods 0.000 title 1
- 229960002620 cefuroxime axetil Drugs 0.000 abstract 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/574,311 US6384213B1 (en) | 1998-10-23 | 2000-05-19 | Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetil |
| PCT/IB2001/000855 WO2001087893A1 (en) | 2000-05-19 | 2001-05-16 | Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE272643T1 true ATE272643T1 (de) | 2004-08-15 |
Family
ID=24295570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01931992T ATE272643T1 (de) | 2000-05-19 | 2001-05-16 | Verfahren zur herstellung eines reinen, pharmacopoiealgrad amorphes form von cefuroxim axetil |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6384213B1 (de) |
| EP (1) | EP1287003B1 (de) |
| JP (1) | JP2003533531A (de) |
| CN (1) | CN1182139C (de) |
| AT (1) | ATE272643T1 (de) |
| AU (1) | AU5867301A (de) |
| BR (1) | BR0110970A (de) |
| DE (1) | DE60104685T2 (de) |
| ES (1) | ES2223843T3 (de) |
| MY (1) | MY117560A (de) |
| WO (1) | WO2001087893A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002068429A1 (en) * | 2001-02-27 | 2002-09-06 | Ranbaxy Laboratories Limited | Process for the preparation of cefpodoxime proxetil |
| US20030135041A1 (en) * | 2002-01-04 | 2003-07-17 | Orchid Chemicals & Pharmaceuticals Limited, India | Synthesis of ceftiofur intermediate |
| WO2004046154A1 (en) * | 2002-11-15 | 2004-06-03 | Orchid Chemicals & Pharmaceuticals Ltd | Novel amorphous hydrate of a cephalosporin antibiotic |
| CN100448879C (zh) * | 2004-07-22 | 2009-01-07 | 北京化工大学 | 一种无定型头孢呋辛酯的制备方法 |
| JP5117190B2 (ja) | 2004-08-27 | 2013-01-09 | コーディス・コーポレイション | 溶媒を含有しない非晶質ラパマイシン |
| DE102008040214A1 (de) | 2008-07-07 | 2010-01-14 | Evonik Röhm Gmbh | Verfahren zur Herstellung von Polyalkylenglykoldi(meth)acrylaten |
| CN116284050B (zh) * | 2022-12-19 | 2024-04-12 | 华北制药河北华民药业有限责任公司 | 一种高效率结晶型头孢呋辛酯转无定型粉体的方法及产品 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1094545A (en) | 1976-02-16 | 1981-01-27 | Michael Gregson | Cephalosporin antibiotics |
| YU44680B (en) | 1982-07-30 | 1990-12-31 | Glaxo Lab Ltd | Process for obtaining very pure amorphous form of cephuroxim axetile |
| GB8320520D0 (en) | 1983-07-29 | 1983-09-01 | Glaxo Group Ltd | Chemical process |
| IT1277426B1 (it) | 1995-08-03 | 1997-11-10 | Acs Dobfar Spa | Forma cristallina biodisponibile del cefuroxima axetil |
| NZ299077A (en) | 1996-07-26 | 1998-06-26 | Apotex Inc | Preparation of amorphous cefuroxime axetil (a cephalosporin derivative) by dissolving crystalline cefuroxim axetil in a highly polar solvent, typically dmso and/or dmf |
| KR100187959B1 (ko) | 1997-03-31 | 1999-06-01 | 윤재승 | 저융점 무정형 세푸록심 악세틸의 제조방법 |
-
2000
- 2000-05-19 US US09/574,311 patent/US6384213B1/en not_active Expired - Fee Related
-
2001
- 2001-05-16 BR BR0110970-7A patent/BR0110970A/pt not_active IP Right Cessation
- 2001-05-16 ES ES01931992T patent/ES2223843T3/es not_active Expired - Lifetime
- 2001-05-16 JP JP2001584287A patent/JP2003533531A/ja active Pending
- 2001-05-16 AT AT01931992T patent/ATE272643T1/de not_active IP Right Cessation
- 2001-05-16 AU AU58673/01A patent/AU5867301A/en not_active Abandoned
- 2001-05-16 DE DE60104685T patent/DE60104685T2/de not_active Expired - Fee Related
- 2001-05-16 CN CNB018116590A patent/CN1182139C/zh not_active Expired - Fee Related
- 2001-05-16 EP EP01931992A patent/EP1287003B1/de not_active Expired - Lifetime
- 2001-05-16 WO PCT/IB2001/000855 patent/WO2001087893A1/en active IP Right Grant
- 2001-05-18 MY MYPI20012371A patent/MY117560A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1182139C (zh) | 2004-12-29 |
| WO2001087893A1 (en) | 2001-11-22 |
| DE60104685D1 (de) | 2004-09-09 |
| DE60104685T2 (de) | 2005-07-14 |
| US6384213B1 (en) | 2002-05-07 |
| AU5867301A (en) | 2001-11-26 |
| ES2223843T3 (es) | 2005-03-01 |
| BR0110970A (pt) | 2003-12-30 |
| EP1287003A1 (de) | 2003-03-05 |
| MY117560A (en) | 2004-07-31 |
| JP2003533531A (ja) | 2003-11-11 |
| CN1439013A (zh) | 2003-08-27 |
| EP1287003B1 (de) | 2004-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE59101734D1 (de) | Verfahren zur herstellung von rhamnose aus rhamnolipiden. | |
| ATE362759T1 (de) | Verfahren zur herstellung von amorphem atorvastatin kalzium | |
| ATE452870T1 (de) | (meth)acrylsaeurekristall und verfahren zur herstellung und aufreinigung von waessriger (meth)acrylsaeure | |
| DE60133083D1 (de) | Verfahren zur herstellung von azithromycin-dihydrat | |
| DE60326341D1 (de) | Verfahren zur herstellung von anthranilsäurederivat-hydrat | |
| JP2004510817A5 (de) | ||
| ATE272643T1 (de) | Verfahren zur herstellung eines reinen, pharmacopoiealgrad amorphes form von cefuroxim axetil | |
| ATE231854T1 (de) | Verfahren zur herstellung von lösemittelfreier alpha-liponsäure | |
| ATE232537T1 (de) | Verfahren zur herstellung von salzen von ascorbyl-2-phosphorsäureestern | |
| ATE157647T1 (de) | Verfahren zur herstellung von alpha- ketoamidderivaten | |
| ATE499345T1 (de) | Verfahren zur aufreinigung von montelukast | |
| ATE373666T1 (de) | Verfahren zur reinigung eines cephalosporin- derivats | |
| DE69602062D1 (de) | Verfahren zur reinigung von diacetylrhein | |
| ATE266635T1 (de) | Verfahren zur herstellung von zofenopril- calciumsalz | |
| ATE238324T1 (de) | Verfahren zur herstellung von polyguluronsäuren | |
| DE3786403D1 (de) | Verfahren zur synthese von n-formyl-aspartyl-phenylalanin und dessen methylester. | |
| DE69114202D1 (de) | Verfahren zur Herstellung von S(+)-6-Methoxy-alpha-methyl-2-naphthalin-Essigsäure. | |
| ATE226954T1 (de) | Verfahren zur fermentativen herstellung von cephalosporin | |
| NO20001137L (no) | Fremgangsmate for a fjerne natriumsulfat fra en fosfatlosning | |
| DE69700903T2 (de) | Verfahren zur Isolierung eines pharmazeutisch verträglichen Alkalimetallsalzes der Clavulansäure | |
| NZ516235A (en) | Method for purification of proteins | |
| ATE457304T1 (de) | Verfahren zur herstellung von 1,2-dichlorethan freien kristallen von zonisamid und hochreinezonisamidkristalle | |
| ATE330932T1 (de) | Verfahren zur herstellung von 3- aminoalkansäureestern | |
| ATE417117T1 (de) | Verfahren zur herstellung von 2-keto-l-gulonsäure | |
| JPH05207888A (ja) | 多糖類の製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |